Detection of copy number alterations in cell-free tumor DNA from plasma

por Østrup, Olga, Ahlborn, Lise Barlebo, Lassen, Ulrik, Mau-Sørensen, Morten, Nielsen, Finn Cilius
Publicado 2017

HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis

por Egebjerg, Kristian, Harwood, Cecilie Dupont, Woller, Nina Claire, Kristensen, Claus Andrup, Mau-Sørensen, Morten
Publicado 2021

Application of cell-free DNA for genomic tumor profiling: a feasibility study

por Ahlborn, Lise B., Rohrberg, Kristoffer S., Gabrielaite, Migle, Tuxen, Ida V., Yde, Christina W., Spanggaard, Iben, Santoni-Rugiu, Eric, Nielsen, Finn C., Lassen, Ulrik, Mau-Sorensen, Morten, Østrup, Olga
Publicado 2019

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors...

por Hurtado, Felipe K., de Braud, Filippo, De Castro Carpeño, Javier, de Miguel Luken, Maria Jose, Wang, Ding, Scott, Jeffrey, Lau, Yvonne Y., McCulloch, Tracey, Mau-Sorensen, Morten
Publicado 2021

Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors

por Ahlborn, Lise Barlebo, Tuxen, Ida Viller, Mouliere, Florent, Kinalis, Savvas, Schmidt, Ane Y., Rohrberg, Kristoffer Staal, Santoni-Rugiu, Eric, Nielsen, Finn Cilius, Lassen, Ulrik, Yde, Christina Westmose, Oestrup, Olga, Mau-Sorensen, Morten
Publicado 2018

High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer

por Bertelsen, Birgitte, Tuxen, Ida Viller, Yde, Christina Westmose, Gabrielaite, Migle, Torp, Mathias Husted, Kinalis, Savvas, Oestrup, Olga, Rohrberg, Kristoffer, Spangaard, Iben, Santoni-Rugiu, Eric, Wadt, Karin, Mau-Sorensen, Morten, Lassen, Ulrik, Nielsen, Finn Cilius
Publicado 2019

Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy

por Borch, Annie, Bjerregaard, Anne-Mette, Araujo Barbosa de Lima, Vinicius, Østrup, Olga, Yde, Christina Westmose, Eklund, Aron Charles, Mau-Sørensen, Morten, Barra, Carolina, Svane, Inge Marie, Nielsen, Finn Cilius, Funt, Samuel A., Lassen, Ulrik, Hadrup, Sine Reker
Publicado 2023

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

por van Bussel, Mark T. J., Awada, Ahmad, de Jonge, Maja J. A., Mau-Sørensen, Morten, Nielsen, Dorte, Schöffski, Patrick, Verheul, Henk M. W., Sarholz, Barbara, Berghoff, Karin, El Bawab, Samer, Kuipers, Mirjam, Damstrup, Lars, Diaz-Padilla, Ivan, Schellens, Jan H. M.
Publicado 2020

A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma

por Lassman, Andrew B., Wen, Patrick Y., van den Bent, Martin J., Plotkin, Scott R., Walenkamp, Annemiek M.E., Green, Adam L., Li, Kai, Walker, Christopher J., Chang, Hua, Tamir, Sharon, Henegar, Leah, Shen, Yao, Alvarez, Mariano J., Califano, Andrea, Landesman, Yosef, Kauffman, Michael G., Shacham, Sharon, Mau-Sørensen, Morten
Publicado 2022